Literature DB >> 16798288

Diagnosis, phenotype, and prevalence of polycystic ovary syndrome.

Enrico Carmina1, Ricardo Azziz.   

Abstract

New diagnostic criteria for polycystic ovary syndrome (PCOS) suggested three main phenotypes: classic (hyperandrogenism and anovulation), ovulatory, and normoandrogenic. However, it is unclear whether the normoandrogenic phenotype actually represents PCOS. Overall, 6% to 8% of reproductive-aged women suffer from PCOS, making this disorder one of the most common endocrine abnormalities.

Entities:  

Mesh：

Year:  2006        PMID： 16798288     DOI： 10.1016/j.fertnstert.2006.03.012

Source DB:  PubMed          Journal:  Fertil Steril        ISSN： 0015-0282            Impact factor:   7.329


  26 in total

1.  Common genetic variation in the 3'-untranslated region of gonadotropin-releasing hormone receptor regulates gene expression in cella and is associated with thyroid function, insulin secretion as well as insulin sensitivity in polycystic ovary syndrome patients.

Authors:  Qiaoli Li; Guizhong Yang; Ying Wang; Xiaoping Zhang; Qing Sang; Huan Wang; Xinzhi Zhao; Qinghe Xing; Lin He; Lei Wang
Journal:  Hum Genet       Date:  2011-01-28       Impact factor: 4.132

2.  Inadequacy of initiating rosuvastatin then metformin on biochemical profile of polycystic ovarian syndrome patients.

Authors:  G Ghazeeri; H A Abbas; B Skaff; S Harajly; J Awwad
Journal:  J Endocrinol Invest       Date:  2015-02-27       Impact factor: 4.256

3.  Morning Circadian Misalignment Is Associated With Insulin Resistance in Girls With Obesity and Polycystic Ovarian Syndrome.

Authors:  Stacey L Simon; Laura McWhirter; Cecilia Diniz Behn; Kate M Bubar; Jill L Kaar; Laura Pyle; Haseeb Rahat; Yesenia Garcia-Reyes; Anne-Marie Carreau; Kenneth P Wright; Kristen J Nadeau; Melanie Cree-Green
Journal:  J Clin Endocrinol Metab       Date:  2019-08-01       Impact factor: 5.958

4.  Low circulating adiponectin levels in women with polycystic ovary syndrome: an updated meta-analysis.

Authors:  Shan Li; Xiamei Huang; Huizhi Zhong; Qiliu Peng; Siyuan Chen; Yantong Xie; Xue Qin; Aiping Qin
Journal:  Tumour Biol       Date:  2014-01-12

5.  Alterations in Glucose Effectiveness and Insulin Dynamics: Polycystic Ovary Syndrome or Body Mass Index.

Authors:  Patricia Vuguin; Aviva B Sopher; Hailey Roumimper; Vivian Chin; Miriam Silfen; Donald J McMahon; Ilene Fennoy; Sharon E Oberfield
Journal:  Horm Res Paediatr       Date:  2017-05-05       Impact factor: 2.852

6.  Dietary underreporting in women affected by polycystic ovary syndrome: A pilot study.

Authors:  Rachele De Giuseppe; Valentina Braschi; David Bosoni; Ginevra Biino; Fatima C Stanford; Rossella E Nappi; Hellas Cena
Journal:  Nutr Diet       Date:  2018-08-05       Impact factor: 2.333

7.  The Effect of Flaxseed Supplementation on Hormonal Levels Associated with Polycystic Ovarian Syndrome: A Case Study.

Authors:  Debra A Nowak; Denise C Snyder; Ann J Brown; Wendy Demark-Wahnefried
Journal:  Curr Top Nutraceutical Res       Date:  2007       Impact factor: 0.416

8.  Improvement in quality-of-life questionnaire measures in obese adolescent females with polycystic ovary syndrome treated with lifestyle changes and oral contraceptives, with or without metformin.

Authors:  Miranda Harris-Glocker; Kristin Davidson; Lynda Kochman; David Guzick; Kathleen Hoeger
Journal:  Fertil Steril       Date:  2009-09-24       Impact factor: 7.329

Review 9.  Oral contraceptives and cardiovascular risk in women with polycystic ovary syndrome.

Authors:  E Carmina
Journal:  J Endocrinol Invest       Date:  2013-02-27       Impact factor: 4.256

10.  Comparing classic and newer phenotypes in Greek PCOS women: the prevalence of metabolic syndrome and their association with insulin resistance.

Authors:  V Vaggopoulos; E Trakakis; C Chrelias; P Panagopoulos; G Basios; S Makridima; V D Sioulas; G Simeonides; G Labos; E Boutati; D Kassanos
Journal:  J Endocrinol Invest       Date:  2012-11-27       Impact factor: 4.256
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.